Comparing two forms of iron supplementation during pregnancy
Official title: Efficacy and Adverse Side Effects of Two Forms of Iron in Prenatal Micronutrient Supplements (EASE-Iron): A Randomized Controlled Trial
Run by University of British Columbia · NCT06014983 · Data updated 2026-11-12
This study is testing which of two types of iron supplements works better for pregnant people to improve their iron levels and overall health.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 19 Years to 42 Years |
| Sex | Women only |
| Enrollment | 172 (estimated) |
| Sponsor | University of British Columbia Academic / other |
| Locations | 2 sites (Vancouver, British Columbia and 1 other locations) |
| Status | Recruiting |
| Started | April 12, 2024 |
| Main results expected | December 2026 |
| Study ends | January 2027 |
| Registry record updated | April 24, 2026 |
| Trial ID | NCT06014983 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are generally healthy, low-risk pregnant individuals aged 19-42 years who are between 13-25 weeks gestation.
✕Probably not a fit
Patients with pre-existing medical conditions affecting iron status or those on medications that interfere with iron metabolism may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the efficacy and side effects of two different forms of iron supplementation, ferrous fumarate and ferrous bisglycinate, in pregnant individuals. A total of 172 healthy, low-risk pregnant participants aged 19-42 years will be recruited in Vancouver, Canada, and randomized to receive one of the two iron supplements along with a prenatal multivitamin. Blood and stool samples will be collected at baseline and follow-up to assess iron levels and gut microbiome changes. The findings will help establish better guidelines for iron supplementation in pregnancy to prevent and treat iron deficiency.
Why it matters
Potential benefit: If successful, this study could lead to improved iron supplementation practices that enhance maternal and fetal health during pregnancy.
How similar studies have gone: Other studies have explored iron supplementation in pregnancy, but this specific comparison of bioavailable forms is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant individual (singleton pregnancy) * 19-42 years of age * Living in the greater Vancouver area and willing to travel to the University of British Columbia or BC Women's Hospital for study visits * 13-25 weeks gestation * Willing to participate and able to provide informed consent Exclusion Criteria: * Having a pre-existing medical condition known to impact iron status (e.g., inherited hemoglobin disorder (i.e., sickle cell, hemochromatosis, thalassemia or other structural hemoglobin variant), malabsorptive disorders (i.e., chronic pancreatitis, cystic fibrosis, celiac disease) and inflammatory bowel disease (i.e., Crohn's disease, ulcerative colitis), gastric bypass surgery, atrophic gastritis, advanced liver disease, kidney dialysis) * Using medications known to interfere with iron metabolism or the gut pathogen equilibrium (e.g., chronic use of proton pump inhibitors, anti-inflammatory agents, non-steroidal anti-inflammatory drugs, antibiotics) * Having a personal neural tube defect (NTD) history or a previous NTD pregnancy * Receiving ongoing blood transfusions * Currently smoking or having smoked in the past 3 months * Pre-pregnancy body mass index (BMI) ≥30 kg/m\^2 * Allergy to any study supplement ingredients
Where it's running
-
BC Women's Hospital
Vancouver, British Columbia, Canada Recruiting -
University of British Columbia, Food, Nutrition and Health Building
Vancouver, British Columbia, Canada Recruiting
Study contacts
- Principal investigator: Crystal Karakochuk, PhD — University of British Columbia
- Study coordinator: Crystal Karakochuk, PhD
- Email: crystal.karakochuk@ubc.ca
- Phone: 604-822-0421
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pregnant Women Living with HIV on Bictegravir/Emtricitabine/Tenofovir Alafenamide
This study looks at how B/F/TAF is used in pregnant women with HIV and whether it helps maintain viral suppression from before conception through delivery.
-
Pelvic Floor Training and a Modified Lumbopelvic Belt for Symphysis Pubis Pain in Pregnancy
This study tests whether pelvic floor muscle training plus a modified lumbopelvic belt can reduce pain and improve function for pregnant women with symphysis pubis pain.
-
Effective Communication in VBAC Counseling
This study tests how clearly doctors and midwives explain VBAC options during prenatal visits and whether patients feel understood.
-
Innovative Multidisciplinary and Virtual Care for IBD in Pregnancy
This study tests a dedicated IBD pregnancy care model, including a new virtual approach, to see if it improves access and quality of care for pregnant people with Crohn's disease or ulcerative colitis.
-
Compare spinal-epidural versus general anesthesia for babies after cesarean delivery
This trial tests whether the type of anesthesia used for cesarean delivery affects newborn hearing in babies.
-
Pregnant women weight-management support via an app and care model
Aims to try a smartphone-based weight-management program plus professional support for pregnant women to see if it helps manage gestational weight and promote healthy behaviors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.